Bayer AG (OTCMKTS:BAYRY) – Equities researchers at Jefferies Group issued their FY2022 earnings per share estimates for shares of Bayer in a note issued to investors on Tuesday. Jefferies Group analyst J. Holford expects that the company will post earnings per share of $2.94 for the year.
Bayer (OTCMKTS:BAYRY) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.29 by $0.14. Bayer had a return on equity of 18.53% and a net margin of 10.88%.
Shares of Bayer (BAYRY) traded up $0.23 on Wednesday, hitting $32.05. The company had a trading volume of 577,546 shares, compared to its average volume of 433,149. The company has a quick ratio of 1.01, a current ratio of 1.51 and a debt-to-equity ratio of 0.67. Bayer has a one year low of $26.98 and a one year high of $35.41. The company has a market capitalization of $104,700.00, a price-to-earnings ratio of 28.11, a P/E/G ratio of 1.82 and a beta of 1.14.
Bayer Company Profile
Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology.
Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.